Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04437758 · ClinicalTrials.gov registry record · NA
Effects of Hydrolyzed Collagen and Vitamin C on Explosive Performance
A NA study, sponsored by PepsiCo Global R&D.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT04437758: Completed NA study, sponsored by PepsiCo Global R&D.
NCT04437758 is a NA study that has completed, run by PepsiCo Global R&D. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04437758, a NA study, has completed, sponsored by PepsiCo Global R&D.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
Determine whether supplementation with a combined dose of 20 g of hydrolyzed collagen and 50 mg vitamin C, along with a power training exercise program, increases rate of force development (RFD) and performance in athletes
Primary Outcome
Force (N) over time (msec) for the maximum slope of the first 20% of the movement
Interventions
- DIETARY_SUPPLEMENT Collagen and Vitamin C powder mix nutritional intervention
- OTHER Maltodextrin placebo powder
- OTHER Maximum power training exercise
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2019-08-22 |
| Est. Completion | 2020-02-05 |
| Phase | NA |
What the finished NCT04437758 record still lists
NCT04437758 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 3 interventions - of which Collagen and Vitamin C powder mix nutritional intervention is the first listed.
NCT04437758 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04437758 about?
NCT04437758 is a clinical study titled "Effects of Hydrolyzed Collagen and Vitamin C on Explosive Performance". Determine whether supplementation with a combined dose of 20 g of hydrolyzed collagen and 50 mg vitamin C, along with a power training exercise program, increases rate of force development (RFD) and performance in athletes
What is the current status of trial NCT04437758?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2019-08-22. Estimated completion is 2020-02-05.
What interventions are being tested in trial NCT04437758?
The interventions under investigation include: Collagen and Vitamin C powder mix nutritional intervention (DIETARY_SUPPLEMENT), Maltodextrin placebo powder (OTHER), Maximum power training exercise (OTHER).
Who is sponsoring clinical trial NCT04437758?
This trial is sponsored by PepsiCo Global R&D, which has 47 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04437758's enrollment target sits among peer trials
50 1279th of 2000 higher than 622 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI